Full-Time

Principal Incident Response Analyst

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Compensation Overview

$123.5k - $222.5kAnnually

+ Annual Cash Bonus + New Hire Equity

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: Seattle, WA, USA

Operating from Cambridge or Seattle.

Category
Cybersecurity
IT & Security
Required Skills
Data Analysis
Requirements
  • A minimum of 10 years of experience in cybersecurity with a significant focus on incident response, security operations and threat intelligence.
  • Proven track record as an incident commander, effectively communicating and delegating tasks to IR analysts of varying levels of expertise.
  • Experience in developing, refining, and maturing IR playbooks and runbooks, ensuring robust and comprehensive incident management processes.
  • Demonstrated ability to coordinate and make critical decisions in ambiguous and high-pressure situations.
  • Technical proficiency in handling complex security incidents, with a deep understanding of the current cybersecurity landscape and threats.
  • Strong leadership skills with the ability to serve as a change agent within the organization.
  • Excellent analytical, critical thinking, and problem-solving skills, with a strong attention to detail.
  • Exceptional communication skills, capable of articulating complex security issues to a diverse range of stakeholders, including C-Suite.
  • Experience in technology change management, project management, business process management, and system implementation.
  • Strong organizational and planning skills, with the ability to manage multiple projects and priorities effectively.
Responsibilities
  • Serve as a strategic partner and driving key incident response initiatives.
  • Take charge during critical incidents as the incident commander, leading a team of IR analysts to rapidly triage, contain, and resolve security events.
  • Develop and implement strategies to enhance in-house efficiency and standardize incident response processes, leveraging AI and digital technologies for improved performance.
  • Create and maintain a comprehensive IR playbook and runbooks, ensuring continuous improvement and alignment with industry best practices.
  • Function as a key decision-maker in ambiguous situations, providing clear direction and coordination to resolve incidents effectively.
  • Collaborate with cross-functional teams to set objectives, drive progress, and achieve meaningful results in the realm of cybersecurity.
  • Develop and track performance metrics and benchmarks through data analytics to measure the effectiveness of the incident response team.
  • Manage relationships with security vendors, including the development of KPIs and cost-efficient billing solutions.
  • Build and maintain internal security knowledge management processes and capabilities.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to leverage the unique properties of mRNA to improve patient outcomes and create a new category of effective treatments.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Opening a new vaccine facility in Victoria enhances manufacturing capabilities.
  • Strategic investment in China boosts Moderna's presence in the Asian market.
  • Collaboration with Carisma Therapeutics could lead to breakthroughs in autoimmune treatments.

What critics are saying

  • Potential removal from Nasdaq 100 could impact investor perception.
  • Reticence in Hong Kong for Covid-19 jab indicates market penetration challenges.
  • Expansion into China may expose Moderna to geopolitical and regulatory risks.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for innovative medical treatments.
  • The company has a strong focus on developing vaccines for infectious diseases.
  • Moderna's mRNA platform enables rapid development of therapeutics and vaccines.

Help us improve and share your feedback! Did you find this helpful?